CorMedix, Inc. (CRMD)
8.28
+0.08
(+0.98%)
USD |
NASDAQ |
Aug 24, 16:00
8.30
+0.02
(+0.24%)
After-Hours: 20:00
CorMedix Price to Book Value : 1.396 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.396 |
| August 21, 2026 | 1.382 |
| August 20, 2026 | 1.387 |
| August 19, 2026 | 1.436 |
| August 18, 2026 | 1.377 |
| August 17, 2026 | 1.293 |
| August 14, 2026 | 1.271 |
| August 13, 2026 | 1.372 |
| August 12, 2026 | 1.197 |
| August 11, 2026 | 1.230 |
| August 10, 2026 | 1.269 |
| August 07, 2026 | 1.254 |
| August 06, 2026 | 1.266 |
| August 05, 2026 | 1.249 |
| August 04, 2026 | 1.267 |
| August 03, 2026 | 1.272 |
| July 31, 2026 | 1.269 |
| July 30, 2026 | 1.262 |
| July 29, 2026 | 1.212 |
| July 28, 2026 | 1.239 |
| July 27, 2026 | 1.281 |
| July 24, 2026 | 1.326 |
| July 23, 2026 | 1.357 |
| July 22, 2026 | 1.338 |
| July 21, 2026 | 1.380 |
| Date | Value |
|---|---|
| July 20, 2026 | 1.311 |
| July 17, 2026 | 1.419 |
| July 16, 2026 | 1.397 |
| July 15, 2026 | 1.419 |
| July 14, 2026 | 1.394 |
| July 13, 2026 | 1.402 |
| July 10, 2026 | 1.416 |
| July 09, 2026 | 1.461 |
| July 08, 2026 | 1.488 |
| July 07, 2026 | 1.495 |
| July 06, 2026 | 1.481 |
| July 02, 2026 | 1.475 |
| July 01, 2026 | 1.428 |
| June 30, 2026 | 1.323 |
| June 29, 2026 | 1.370 |
| June 26, 2026 | 1.408 |
| June 25, 2026 | 1.385 |
| June 24, 2026 | 1.505 |
| June 23, 2026 | 1.543 |
| June 22, 2026 | 1.582 |
| June 18, 2026 | 1.555 |
| June 17, 2026 | 1.555 |
| June 16, 2026 | 1.553 |
| June 15, 2026 | 1.541 |
| June 12, 2026 | 1.568 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Innoviva, Inc. | 1.239 |
| Zevra Therapeutics, Inc. | 3.176 |
| Filana Therapeutics, Inc. | 0.7063 |
| Eloxx Pharmaceuticals, Inc. | 1.738 |
| Cannabis Global, Inc. | -- |
Price to Book Value Related Metrics
| PE Ratio | 3.934 |
| PS Ratio | 1.637 |
| PEG Ratio | 0.0216 |
| Price to Free Cash Flow | 3.026 |
| Price | 8.28 |
| Earnings Yield | 25.42% |
| Market Cap | 643.08M |
| PEGY Ratio | 0.0216 |
| Operating PE Ratio | 3.487 |
| Normalized PE Ratio | 3.760 |